Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Treatment with Hetrombopag for Poor Platelet Engraftment after Allo-HSCT-a Single Center Retrospective, Observational Study

Gangping Li, Yongqi Wang, Ziye Li, Fangfang Yuan, Minghui Li, Yuewen Fu

Blood (2023) 142 (Supplement 1): 6965.

https://doi.org/10.1182/blood-2023-185506

Published: 2023

Journal Articles

Organ-Specific Protection from CD8 + T Cell-Mediated Acute Skin GVHD by Bortezomib Administration Correlates with Decreased IL-6.

Kai Sun, MD, Gail Sckisel, Julia Tietze, MD, Minghui Li, PhD, Thomas Sayers, PhD, Bruce R. Blazar, MD, William J. Murphy, PhD

Blood (2010) 116 (21): 3735.

https://doi.org/10.1182/blood.V116.21.3735.3735

Published: 2010

Journal Articles

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

Minghui Li, Kai Sun, Mark Hubbard, Doug Redelman, Angela Panoskaltsis-Mortari, Sergei Nedospasov, Dennis Taub, Bruce Blazar, Lisbeth A. Welniak, William J. Murphy

Blood (2008) 112 (11): 3482.

https://doi.org/10.1182/blood.V112.11.3482.3482

Published: 2008

Journal Articles

Donor T Cells Lacking IFN-Gamma Receptor Expression Enhance Donor Myeloid Engraftment and Decrease Early Acute Graft-Versus-Host Disease Mortality Following Allogeneic Bone Marrow Transplantation

Kai Sun, MD, Minghui Li, Mark A. Hubbard, Lisbeth A. Welniak, PhD, William J. Murphy, PhD

Blood (2008) 112 (11): 3514.

https://doi.org/10.1182/blood.V112.11.3514.3514

Published: 2008

Journal Articles

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Kai Sun, Minghui Li, Thomas J. Sayers, Lisbeth A. Welniak, William J. Murphy

Blood (2008) 112 (4): 1522–1529.

https://doi.org/10.1182/blood-2008-03-143461

Published: 2008

Journal Articles

Dissociating GVT from GVHD in Murine BMT Models through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.

William J. Murphy, PhD, Minghui Li, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Thomas J. Sayers, PhD, Sergei Nedospasov, PhD, Dennis D. Taub, PhD, Lisbeth A. Welniak, PhD, Kai Sun, PhD

Blood (2007) 110 (11): 69.

https://doi.org/10.1182/blood.V110.11.69.69

Published: 2007

Journal Articles

Removal of Donor CD4+ T Cells Markedly Promotes Graft-Versus-Tumor (GVT) Effects and Inhibits GVHD-Dependent Toxicity Associated with Prolonged Bortezomib Administration after Allogeneic BMT.

William J. Murphy, PhD, Lisbeth A. Welniak, PhD, Minghui Li, Thomas J. Sayers, PhD, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Kai Sun, MD, PhD

Blood (2006) 108 (11): 3160.

https://doi.org/10.1182/blood.V108.11.3160.3160

Published: 2006

NARROW

Treatment with Hetrombopag for Poor Platelet Engraftment after Allo-HSCT-a Single Center Retrospective, Observational Study

Organ-Specific Protection from CD8 + T Cell-Mediated Acute Skin GVHD by Bortezomib Administration Correlates with Decreased IL-6.

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

Donor T Cells Lacking IFN-Gamma Receptor Expression Enhance Donor Myeloid Engraftment and Decrease Early Acute Graft-Versus-Host Disease Mortality Following Allogeneic Bone Marrow Transplantation

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Dissociating GVT from GVHD in Murine BMT Models through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.

Removal of Donor CD4+ T Cells Markedly Promotes Graft-Versus-Tumor (GVT) Effects and Inhibits GVHD-Dependent Toxicity Associated with Prolonged Bortezomib Administration after Allogeneic BMT.

Email alerts

ASH Publications

American Society of Hematology

Treatment with Hetrombopag for Poor Platelet Engraftment after Allo-HSCT-a Single Center Retrospective, Observational Study

Organ-Specific Protection from CD8 + T Cell-Mediated Acute Skin GVHD by Bortezomib Administration Correlates with Decreased IL-6.

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

Donor T Cells Lacking IFN-Gamma Receptor Expression Enhance Donor Myeloid Engraftment and Decrease Early Acute Graft-Versus-Host Disease Mortality Following Allogeneic Bone Marrow Transplantation

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Dissociating GVT from GVHD in Murine BMT Models through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.

Removal of Donor CD4+ T Cells Markedly Promotes Graft-Versus-Tumor (GVT) Effects and Inhibits GVHD-Dependent Toxicity Associated with Prolonged Bortezomib Administration after Allogeneic BMT.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only